These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 30220419

  • 21. Impact of new task force criteria in the diagnosis of arrhythmogenic right ventricular cardiomyopathy.
    Femia G, Hsu C, Singarayar S, Sy RW, Kilborn M, Parker G, McGuire M, Semsarian C, Puranik R.
    Int J Cardiol; 2014 Feb 01; 171(2):179-83. PubMed ID: 24342399
    [Abstract] [Full Text] [Related]

  • 22. Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia.
    Saberniak J, Leren IS, Haland TF, Beitnes JO, Hopp E, Borgquist R, Edvardsen T, Haugaa KH.
    Eur Heart J Cardiovasc Imaging; 2017 Jan 01; 18(1):62-69. PubMed ID: 26903598
    [Abstract] [Full Text] [Related]

  • 23. Right ventricular scalloping index as cardiac magnetic resonance-derived marker for diagnosis of arrhythmogenic right ventricular cardiomyopathy.
    Huang KY, Chung FP, Guo CY, Chiu JH, Kuo L, Lee YC, Weng CY, Chang YY, Lin YJ, Chen CK.
    J Chin Med Assoc; 2024 May 01; 87(5):531-537. PubMed ID: 38529961
    [Abstract] [Full Text] [Related]

  • 24. Importance of CMR within the Task Force Criteria for the diagnosis of ARVC in children and adolescents.
    Etoom Y, Govindapillai S, Hamilton R, Manlhiot C, Yoo SJ, Farhan M, Sarikouch S, Peters B, McCrindle BW, Grosse-Wortmann L.
    J Am Coll Cardiol; 2015 Mar 17; 65(10):987-95. PubMed ID: 25766945
    [Abstract] [Full Text] [Related]

  • 25. Current Concepts on Diagnosis and Prognosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia.
    Castaños Gutiérrez SL, Kamel IR, Zimmerman SL.
    J Thorac Imaging; 2016 Nov 17; 31(6):324-335. PubMed ID: 26429589
    [Abstract] [Full Text] [Related]

  • 26. Prognostic value of right ventricular trabecular complexity in patients with arrhythmogenic cardiomyopathy.
    Chen BH, Jiang WY, Zheng JY, Dai YS, Shi RY, Wu R, An DA, Tang LL, Xu JR, Zhao L, Wu LM.
    Eur Radiol; 2024 Aug 17; 34(8):4883-4896. PubMed ID: 38189980
    [Abstract] [Full Text] [Related]

  • 27. Right ventricular outflow tract dimensions in arrhythmogenic right ventricular cardiomyopathy/dysplasia-a multicentre study comparing echocardiography and cardiovascular magnetic resonance.
    Gotschy A, Saguner AM, Niemann M, Hamada S, Akdis D, Yoon JN, Parmon EV, Delgado V, Bax JJ, Kozerke S, Brunckhorst C, Duru F, Tanner FC, Manka R.
    Eur Heart J Cardiovasc Imaging; 2018 May 01; 19(5):516-523. PubMed ID: 28575228
    [Abstract] [Full Text] [Related]

  • 28. Comparison of cardiovascular magnetic resonance characteristics and clinical prognosis in left ventricular noncompaction patients with and without arrhythmia.
    Zhou ZQ, He WC, Li X, Bai W, Huang W, Hou RL, Wang YN, Guo YK.
    BMC Cardiovasc Disord; 2022 Feb 02; 22(1):25. PubMed ID: 35109817
    [Abstract] [Full Text] [Related]

  • 29. Right Ventricular Strain and Dyssynchrony Assessment in Arrhythmogenic Right Ventricular Cardiomyopathy: Cardiac Magnetic Resonance Feature-Tracking Study.
    Prati G, Vitrella G, Allocca G, Muser D, Buttignoni SC, Piccoli G, Morocutti G, Delise P, Pinamonti B, Proclemer A, Sinagra G, Nucifora G.
    Circ Cardiovasc Imaging; 2015 Nov 02; 8(11):e003647; discussion e003647. PubMed ID: 26534932
    [Abstract] [Full Text] [Related]

  • 30. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G, Guaricci AI, Andreini D, Solbiati A, Guglielmo M, Mushtaq S, Baggiano A, Beltrama V, Fusini L, Rota C, Segurini C, Conte E, Gripari P, Dello Russo A, Moltrasio M, Tundo F, Lombardi F, Muscogiuri G, Lorenzoni V, Tondo C, Agostoni P, Bartorelli AL, Pepi M.
    Circ Cardiovasc Imaging; 2016 Oct 02; 9(10):. PubMed ID: 27729359
    [Abstract] [Full Text] [Related]

  • 31. Biventricular myocardial strain analysis in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) using cardiovascular magnetic resonance feature tracking.
    Heermann P, Hedderich DM, Paul M, Schülke C, Kroeger JR, Baeßler B, Wichter T, Maintz D, Waltenberger J, Heindel W, Bunck AC.
    J Cardiovasc Magn Reson; 2014 Oct 07; 16(1):75. PubMed ID: 25315082
    [Abstract] [Full Text] [Related]

  • 32. Left ventricular involvement assessed by LGE-CMR in predicting the risk of adverse outcomes of arrhythmogenic cardiomyopathy with ICDs.
    Zhang N, Song Y, Hua W, Hu Y, Chen L, Cai M, Niu H, Cai C, Gu M, Zhao S, Zhang S.
    Int J Cardiol; 2021 Aug 15; 337():79-85. PubMed ID: 33839174
    [Abstract] [Full Text] [Related]

  • 33. Ventricular structure in ARVC: going beyond volumes as a measure of risk.
    McLeod K, Wall S, Leren IS, Saberniak J, Haugaa KH.
    J Cardiovasc Magn Reson; 2016 Oct 14; 18(1):73. PubMed ID: 27756409
    [Abstract] [Full Text] [Related]

  • 34. Comparative study of CMR characteristics between arrhythmogenic right ventricular cardiomyopathy patients with/without syncope.
    Cheng H, Lu M, Hou C, Chen X, Wang J, Li L, Wan J, Yin G, Chu J, Prasad SK, Zhang S, Pu J, Zhao S.
    Int J Cardiovasc Imaging; 2014 Oct 14; 30(7):1365-72. PubMed ID: 25026910
    [Abstract] [Full Text] [Related]

  • 35. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M, De Lazzari M, Zorzi A, Migliore F, Zilio F, Calore C, Vettor G, Tona F, Tarantini G, Cacciavillani L, Corbetti F, Giorgi B, Miotto D, Thiene G, Basso C, Iliceto S, Corrado D.
    Heart Rhythm; 2014 May 14; 11(5):856-63. PubMed ID: 24440822
    [Abstract] [Full Text] [Related]

  • 36. Impact of the revision of arrhythmogenic right ventricular cardiomyopathy/dysplasia task force criteria on its prevalence by CMR criteria.
    Vermes E, Strohm O, Otmani A, Childs H, Duff H, Friedrich MG.
    JACC Cardiovasc Imaging; 2011 Mar 14; 4(3):282-7. PubMed ID: 21414577
    [Abstract] [Full Text] [Related]

  • 37. Multimodality Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Malik N, Mukherjee M, Wu KC, Zimmerman SL, Zhan J, Calkins H, James CA, Gilotra NA, Sheikh FH, Tandri H, Kutty S, Hays AG.
    Circ Cardiovasc Imaging; 2022 Feb 14; 15(2):e013725. PubMed ID: 35147040
    [Abstract] [Full Text] [Related]

  • 38. Right ventricular systolic function and mechanical dispersion identify patients with arrhythmogenic right ventricular cardiomyopathy.
    Åström Aneq M, Maret E, Brudin L, Svensson A, Engvall J.
    Clin Physiol Funct Imaging; 2018 Sep 14; 38(5):779-787. PubMed ID: 29105955
    [Abstract] [Full Text] [Related]

  • 39. Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis.
    Wan K, Sun J, Han Y, Luo Y, Liu H, Yang D, Cheng W, Zhang Q, Zeng Z, Chen Y.
    Heart Vessels; 2018 Feb 14; 33(2):170-179. PubMed ID: 28840397
    [Abstract] [Full Text] [Related]

  • 40. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy: Progress and Pitfalls.
    Oomen AWGJ, Semsarian C, Puranik R, Sy RW.
    Heart Lung Circ; 2018 Nov 14; 27(11):1310-1317. PubMed ID: 29705385
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.